Press releases and News

2022-11-16 09:05
The European Society of Anaesthesiology and Intensive Care (ESAIC) strongly recommends the use of quantitative neuromuscular monitoring to prevent complications related to muscle relaxants. Senzime’s TetraGraph® system fulfills these new guidelines...
2022-11-10 14:30
Senzime AB (publ) invites investors, financial analysts and media to a digital investor event on November 15, 2022, at 13:00-15:00 CET. Pia Renaudin, CEO, will together with Kay Krüger (Business manager ExSpiron products) and Sorin J. Brull (Professor...
2022-10-27 10:00
Uppsala, October 27, 2022. Senzime AB (publ) today announced that the American Society of Anesthesiologists (ASA) has voted on final approval of clinical guidelines for monitoring and reversal of neuromuscular blockade. This is the first time that ASA...
2022-10-25 10:00
Senzime AB (publ) invites investors, financial analysts and media to a digital investor event on November 15, 2022, in the afternoon. The purpose is to give an update of the strategy following the acquisition of Respiratory Motion, describe the market...
2022-09-07 11:50
Uppsala, Sweden. September 7, 2022: Senzime today announced that a study published ahead of print in the Saudi Journal of Anesthesia concludes that TetraGraph, the company’s electromyography (EMG)-based monitor, is effective for monitoring neuromuscular...
2022-08-05 08:30
News: Uppsala, August 5, 2022. Senzime announces today the launch of TetraGraph® Xcom, a solution that enables communication between the TetraGraph® and Philips Capsule Medical Device Information Platform (MDIP). The integration enables the electronic...
2022-06-02 09:20
Senzime AB (publ), announced on June 1 that the company has entered into an agreement to acquire the US company Respiratory Motion. Following this announcement, Senzime invites investors, analysts, and media to an webcast (in English) with a Q&A-session...
2022-04-04 14:30
News: Uppsala, on April 4, 2022. Senzime today announces that the recently launched single-use sensor for children, TetraSens Pediatric, received great interest when it was shown at the congress SPA Pediatric Anesthesiology 2022. Several studies were...
2022-03-25 10:45
Press release: Uppsala, March 25, 2022. Senzime announces today that the use of the TetraGraph system has been expanded to include small children with the CE-MDR approval of the new disposable and EMG-based TetraSens Pediatric. Senzime's system for monitoring...
2022-03-24 12:45
Press release: Uppsala March 24, 2022. Senzime announces today that the company has won an order from a large American academic healthcare system in the upper Midwest. This is a three-hospital facility affiliated with a School of Medicine. The order includes...

Contact us

Want to know more?

How can Senzime’s innovative patient monitoring solutions help to eliminate in-hospital complications?
Contact us today.